US judge voids HHS vaccine-panel appointments
Pharmacy vaccinators lose federal liability protection for updated flu, Covid and infant RSV shots
Change
A US federal judge has voided the Department of Health and Human Services secretary’s appointments to the Advisory Committee on Immunization Practices (ACIP), invalidating those advisers and removing ACIP recommendations for the updated seasonal flu, updated Covid and the infant RSV vaccine in the Vaccines for Children program until a properly constituted committee issues new recommendations.
Why it matters
Absent an active ACIP endorsement, the federal liability shield under the Public Readiness and Emergency Preparedness (PREP) Act does not automatically apply to providers who administer the updated flu, Covid or infant RSV vaccines. State laws vary: some states restrict pharmacy administration when ACIP has no recommendation, while others permit administration only when professional bodies such as the American Academy of Pediatrics provide recognition, creating immediate legal variability for vaccinators.
Implications
- — Pharmacy vaccinators must withhold administration of the updated seasonal influenza, updated Covid and infant RSV vaccines immediately unless a current ACIP recommendation or a state-authorised alternative is available — otherwise they forfeit PREP Act federal liability protection and risk state-level enforcement limits.
- — Health-system legal and compliance teams must amend standing orders and informed-consent protocols before offering these vaccines or face malpractice coverage gaps and regulatory liability when staff administer shots without ACIP-backed protection.
Unlock the full brief.
Implications — what this forces you to change
Who is affected — which roles and obligations are exposed
What to watch — binding deadlines and enforcement dates
Real-time alerts — delivered the moment a binding change is published
Clarify with AI — turn any brief into a decision for your role
Start free trial
No credit card · $29/month (~₹2,400) after trial · Active in seconds
Source
View on The Guardian